Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 100

    1.

    Too much glucagon, too little insulin: time course of pancreatic islet dysfunction in new-onset type 1 diabetes.

    Brown RJ, Sinaii N, Rother KI.

    Diabetes Care. 2008 Jul;31(7):1403-4.PMID: 18594062 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.

    Pampanelli S, Torlone E, Ialli C, Del Sindaco P, Ciofetta M, Lepore M, Bartocci L, Brunetti P, Bolli GB.

    Diabetes Care. 1995 Nov;18(11):1452-9.PMID: 8722069 [PubMed - indexed for MEDLINE]Related articles

    3.

    Beta-cell function in relation to islet cell antibodies during the first 3 yr after clinical diagnosis of diabetes in type II diabetic patients.

    Gottsäter A, Landin-Olsson M, Fernlund P, Lernmark A, Sundkvist G.

    Diabetes Care. 1993 Jun;16(6):902-10.PMID: 8325204 [PubMed - indexed for MEDLINE]Related articles

    4.

    Endocrine pancreatic response of children with onset of insulin-requiring diabetes before age 3 and after age 5.

    Ternand C, Go VL, Gerich JE, Haymond MW.

    J Pediatr. 1982 Jul;101(1):36-9.PMID: 7045315 [PubMed - indexed for MEDLINE]Related articles

    5.

    Impaired beta-cell and alpha-cell function in African-American children with type 2 diabetes mellitus--"Flatbush diabetes".

    Banerji MA.

    J Pediatr Endocrinol Metab. 2002 Apr;15 Suppl 1:493-501. Review.PMID: 12017222 [PubMed - indexed for MEDLINE]Related articles

    6.

    Factors influencing the magnitude, duration, and rate of fall of B-cell function in type 1 (insulin-dependent) diabetic children followed for two years from their clinical diagnosis.

    Wallensteen M, Dahlquist G, Persson B, Landin-Olsson M, Lernmark A, Sundkvist G, Thalme B.

    Diabetologia. 1988 Sep;31(9):664-9.PMID: 3069534 [PubMed - indexed for MEDLINE]Related articles

    7.

    Insulin secretion in type 1 diabetes.

    Steele C, Hagopian WA, Gitelman S, Masharani U, Cavaghan M, Rother KI, Donaldson D, Harlan DM, Bluestone J, Herold KC.

    Diabetes. 2004 Feb;53(2):426-33.PMID: 14747294 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.

    Vilsbøll T, Krarup T, Sonne J, Madsbad S, Vølund A, Juul AG, Holst JJ.

    J Clin Endocrinol Metab. 2003 Jun;88(6):2706-13.PMID: 12788877 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Pancreatic beta-cell function in cirrhotic patients with and without overt diabetes. C-peptide response to glucagon and to meal.

    Marchesini G, Melli A, Checchia GA, Mattioli L, Capelli M, Cassarani S, Zoli M, Pisi E.

    Metabolism. 1985 Aug;34(8):695-701.PMID: 3894876 [PubMed - indexed for MEDLINE]Related articles

    10.

    C-peptide and glucagon profiles in minority children with type 2 diabetes mellitus.

    Umpaichitra V, Bastian W, Taha D, Banerji MA, AvRuskin TW, Castells S.

    J Clin Endocrinol Metab. 2001 Apr;86(4):1605-9.PMID: 11297591 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Immunoreactive gastric inhibitory polypeptide response to a meal during the first eighteen months after diagnosis of type 1 (insulin dependent) diabetes mellitus.

    Krarup T, Madsbad S, Moody AJ.

    J Clin Endocrinol Metab. 1985 Jan;60(1):120-5.PMID: 3880559 [PubMed - indexed for MEDLINE]Related articles

    12.

    Beta-cell response to intravenous glucagon in African-American and Hispanic children with type 2 diabetes mellitus.

    Taha DR, Castells S, Umpaichitra V, Bastian W, Banerji MA.

    J Pediatr Endocrinol Metab. 2002 Jan;15(1):59-67.PMID: 11822582 [PubMed - indexed for MEDLINE]Related articles

    13.

    Impaired beta-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose.

    Greenbaum CJ, Prigeon RL, D'Alessio DA.

    Diabetes. 2002 Apr;51(4):951-7.PMID: 11916912 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Prospective study of predictors of beta-cell survival in type I diabetes.

    Schiffrin A, Suissa S, Poussier P, Guttmann R, Weitzner G.

    Diabetes. 1988 Jul;37(7):920-5.PMID: 3290010 [PubMed - indexed for MEDLINE]Related articles

    15.

    The effect of glipizide gastrointestinal therapeutic system on islet cell hormonal responses to a test meal in NIDDM.

    Mooradian AD, Albert SG, Bernbaum M, Plummer S.

    Diabetes Care. 1996 Aug;19(8):883-4.PMID: 8842609 [PubMed - indexed for MEDLINE]Related articles

    16.

    Homogeneity in pattern of decline of beta-cell function in IDDM. Prospective study of 204 consecutive cases followed for 7.4 yr.

    Snorgaard O, Lassen LH, Binder C.

    Diabetes Care. 1992 Aug;15(8):1009-13.PMID: 1505301 [PubMed - indexed for MEDLINE]Related articles

    17.

    Residual insulin secretion is not coupled to a maintained glucagon response to hypoglycaemia in long-term type 1 diabetes.

    Sjöberg S, Ahrén B, Bolinder J.

    J Intern Med. 2002 Oct;252(4):342-51.PMID: 12366607 [PubMed - indexed for MEDLINE]Related articles

    18.

    Meal-stimulated glucagon release is associated with postprandial blood glucose level and does not interfere with glycemic control in children and adolescents with new-onset type 1 diabetes.

    Pörksen S, Nielsen LB, Kaas A, Kocova M, Chiarelli F, Orskov C, Holst JJ, Ploug KB, Hougaard P, Hansen L, Mortensen HB; Hvidøre Study Group on Childhood Diabetes.

    J Clin Endocrinol Metab. 2007 Aug;92(8):2910-6. Epub 2007 May 22.PMID: 17519307 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Disproportionately elevated proinsulin levels precede the onset of insulin-dependent diabetes mellitus in siblings with low first phase insulin responses. The Childhood Diabetes in Finland Study Group.

    Røder ME, Knip M, Hartling SG, Karjalainen J, Akerblom HK, Binder C.

    J Clin Endocrinol Metab. 1994 Dec;79(6):1570-5.PMID: 7989457 [PubMed - indexed for MEDLINE]Related articles

    20.

    High-dose intravenous insulin infusion versus intensive insulin treatment in newly diagnosed IDDM.

    Schnell O, Eisfelder B, Standl E, Ziegler AG.

    Diabetes. 1997 Oct;46(10):1607-11.PMID: 9313757 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data